drugset / Trial / NCT04943536
Bicalutamide Implants (Biolen) With Radiation Therapy in Patients With Localized Prostate Cancer
Phase 1
Active not recruiting
20 enrolled
Alessa Therapeutics Inc.
National Cancer Institute (NCI) · collab
NaSingle-groupOpen-labelTreatment
Summary
This study will be undertaken to evaluate the feasibility of replacing systemic Androgen Deprivation Therapy (ADT) with targeted local delivery of an anti-androgen agent alone in patients in whom ADT + radiation therapy is indicated for the treatment of localized prostate cancer.
Timeline
- Start
- 2021-12-07
- Primary completion
- 2027-04-24
- Completion
- 2027-08-15
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Bicalutamide | Other / unclassified | — | Other |